440O Afatinib (A) vs gefitinib (G) in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7)

K. Park, Enhu Tan, L. Zhang, V. Hirsh, K. O'Byrne, M. Boyer, J.C-H. Yang, T. Mok, K.H. Lee, S. Lu, Yuheng Shi, S-W. Kim, J. Laskin, Dongwook Kim, S.A. Laurie, K. Kölbeck, J. Fan, N. Dodd, A. Märten, L. Paz-Ares
Annals of Oncology
December 1, 2016
10.1093/annonc/mdw594.004
Cited by 0Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis